ArticleFrontiers in microbiology2026
Basecalling-free resistance gene identification using a hybrid transformer in raw nanopore signals.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanopore sequencing enables real-time access to raw signal data, which brings new possibilities for rapid genomic diagnostics. However, current workflows still primarily rely on basecalling, a computationally intensive step that slows subsequent analysis and limits real-time use. In addition, most current approaches that work with raw signals focus on simple read-level classification tasks and are not designed to detect and localize specific genes, particularly complex genomic features such as antibiotic resistance genes (ARGs). Here, we show that the hybrid convolutional-transformer model, NanoResFormer, can detect clinically relevant ARGs directly from raw nanopore signals without basecalling. The model captures both local and long-range signal patterns and employs a floating-window strategy to process inputs of varying lengths efficiently. In proof-of-concept experiments, NanoResFormer achieved a sensitivity of 92.6% and a precision of over 93%, with short latency, enabling real-time resistome profiling already during sequencing. The proposed approach, therefore, provides rapid access to crucial information, accelerating decision-making in clinical diagnostics and pathogen surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.